Publication: Serum oncofetal fibronectin (onfFN) mrna in differentiated thyroid carcinoma (DTC): Large overlap between disease- free and metastatic patients
Submitted Date
Received Date
Accepted Date
Issued Date
2012-01-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
2476762X
15137368
15137368
eISSN
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-84873627437
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Asian Pacific Journal of Cancer Prevention. Vol.13, No.8 (2012), 4203-4208
Citation
Chanika Sritara, Putthiporn Charoenphun, Mathurose Ponglikitmongkol, Suchawadee Musikarat, Chirawat Utamakul, Payap Chokesuwattanasakul, Ammarin Thakkinstian (2012). Serum oncofetal fibronectin (onfFN) mrna in differentiated thyroid carcinoma (DTC): Large overlap between disease- free and metastatic patients. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/13836.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Serum oncofetal fibronectin (onfFN) mrna in differentiated thyroid carcinoma (DTC): Large overlap between disease- free and metastatic patients
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
Aim: This study assessed if onfFN mRNA in the peripheral blood of patients with DTC can identify individuals with metastatic disease. Methods: Comparison of onfFN mRNA was made among 3 groups: disease-free, lymph node metastasis, and distant metastasis using real-time RT-PCR on 5 ml blood samples from each DTC patient. Results: Fifty-one patients were included: 30 (59%) were disease-free; 7 (13.7%) had lymph node metastasis; and 14 (27.5%) had distant metastasis. OnfFN mRNA levels in the 3 groups were significantly different (P=0.001) but with a large overlap and the expression being highest in the disease-free group. Subgroup analysis of the metastatic groups did not show any effect of age, cell type, and serum TSH, Tg, and antiTg on onfFN mRNA. The within-run and between-run root mean square coefficients of variations were < 2%. Conclusion: OnfFN mRNA in patients with DTC cannot identify those with metastatic disease.